WO1993010723A1 - Balloon prosthesis for lung and methods - Google Patents

Balloon prosthesis for lung and methods Download PDF

Info

Publication number
WO1993010723A1
WO1993010723A1 PCT/US1992/010252 US9210252W WO9310723A1 WO 1993010723 A1 WO1993010723 A1 WO 1993010723A1 US 9210252 W US9210252 W US 9210252W WO 9310723 A1 WO9310723 A1 WO 9310723A1
Authority
WO
WIPO (PCT)
Prior art keywords
balloon
prosthesis
chest cavity
lung
subcutaneous
Prior art date
Application number
PCT/US1992/010252
Other languages
French (fr)
Inventor
Robert L. Johnson, Jr.
Connie C. W. Hsia
Original Assignee
Board Of Regents, The University Of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Board Of Regents, The University Of Texas System filed Critical Board Of Regents, The University Of Texas System
Publication of WO1993010723A1 publication Critical patent/WO1993010723A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0063Implantable repair or support meshes, e.g. hernia meshes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/02Devices for expanding tissue, e.g. skin tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2/30942Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2002/043Bronchi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30535Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30537Special structural features of bone or joint prostheses not otherwise provided for adjustable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30667Features concerning an interaction with the environment or a particular use of the prosthesis
    • A61F2002/30706Features concerning an interaction with the environment or a particular use of the prosthesis specially designed for children, e.g. having means for adjusting to their growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0004Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0082Additional features; Implant or prostheses properties not otherwise provided for specially designed for children, e.g. having means for adjusting to their growth

Definitions

  • This invention relates to prosthetic appliances for humans and other animals, and in particular it relates to a prosthetic device to occupy the chest cavity left vacant after excision of a lung.
  • the prosthesis of this invention performs the separating and supporting functions performed by the lung, without interfering with the performance of the heart or any other organs and without impairing the breathing function of the remaining lung.
  • This invention also relates to a method for making and using such a prosthesis.
  • pneumonectomy The removal of one lung (i.e. pneumonectomy) is a surgical procedure not uncommonly performed for cancer, trauma, or infection of the lung.
  • Prevention of overdistension of the remaining lung after pneumonectomy has been a concern to thoracis surgeons for many years. They anticipated that overdistension would cause distortions of remaining structures inside the thorax leading to abnormal heart and lung function.
  • Many surgical procedures were designed to prevent overexpansion.
  • investigators placed hollow lucite balls in the vacant chest cavities of dogs and humans to prevent overdistension of the remaining lung and to maintain the mediastinum in the midline following pneumonectomy. This work was described in Johnson et al . , Journal of Thoracic Sur ⁇ ery 18:164 (1949).
  • Other substances and devices have been used to replace an excised lung and to correct the problems associated therewith, including gelatin foam, plastic sponge (Ivalon) and a polythene bag filled with fiberglass. Since the early 1960's these procedures have generally been abandoned as unnecessary.
  • tissue expanders Numerous types of tissue expanders have been used by medical practitioners, such as those disclosed in, for example, U.S. Patent Nos. 4,095,295, 4,643,733, 4,800,901, 4,685,446, and 4,969,899. These are all designed for use in muscular and cutaneous tissue and are filled with a fluid or gelatinous material. Ordinary tissue expanders are not well suited for use as lung prostheses, however, because (a) they do not conform to the shape of the lung, so normal anatomy is not restored, (b) they generally contain saline, which is heavy and which does not restore normal compliance around the heart, and (c) they are not expandable to the extent required to permit implantation in a child and subsequent expansion to accommodate normal growth.
  • a lung prosthesis be adapted to permit adjustment to its volume by injection and withdrawal of fluid (liquid or gas) without additional surgery, and that the prosthesis be expandable to permit its use in a growing patient by periodically injecting additional fluid to increase the volume of the prosthesis.
  • the goals outlined above are in large part achieved by the device and method of the present invention.
  • a method of preventing mediastinal shift and overdistension and displacement of the remaining organs after pneumonectomy is provided.
  • the lung prosthesis according to this invention is hollow and lightweight, yet it effectively and compliantly supports the heart and mediastinal structures and inhibits their movement from normal positions, preventing adhesion of the heart to other structures to avoid fibrous encasement of the heart.
  • the prosthesis may be custom molded to fit the chest cavity into which it is intended to be placed and provided with a subcutaneous septal port which allows fluid to be injected into and withdrawn from the implanted prosthesis without additional surgery.
  • An elastic material may be chosen to construct the prosthesis to permit volume changes as the patient grows.
  • the prosthesis may be designed to allow for uniform expansion of the prosthesis to accommodate growth of a young patient while maintaining its anatomically correct shape over a range of volumes.
  • the custom molding method of making a balloon prosthesis comprises obtaining a computer model of the chest cavity the prosthesis is intended to occupy using non-invasive imaging techniques, for example, magnetic resonance imaging or computer to ographic (CT) scanning.
  • CT computer to ographic
  • a three dimensional physical model may be made based on the computer model, from which a mold may be constructed to form the balloon.
  • the computer model may be generated at the hospital or clinic where the patient is examined and transferred to the balloon fabricator, or it may be generated by the fabricator.
  • the invention also includes a method for preventing mediastinal shift and overdistension and displacement of organs following pneumonectomy, comprising providing a prosthetic balloon as described herein, implanting it in a patient following pneumonectomy, filling the balloon with fluid, and adjusting the volume of the balloon as desired.
  • the balloon may be implanted at the time of surgery to remove the damaged lung, and the balloon may be filled to occupy the vacant chest cavity without being under tension and without applying pressure to the adjacent organs and structures.
  • the volume of the balloon may be adjusted without requiring surgery by accessing the subcutaneous septal port of the preferred embodiment with a hypodermic needle and selectively injecting or withdrawing fluid from the prosthesis.
  • the prosthesis may be filled with either gas or liquid.
  • a gaseous filler is desirable so the volume inside the prosthesis can be periodically adjusted, and the gas composition, may be selected to minimize volume change due to transfer of gas across the wall of the prosthesis.
  • the gas may be withdrawn and replaced with a light liquid such as a silicone solution.
  • the present invention therefore provides an improved prosthesis for occupying the vacant chest cavity after a pneumonectomy. It also provides methods for making the prosthesis and for using the prosthesis to prevent or correct mediastinal shift and overdistension of the remaining lung, and to provide a substitute cardiac fossa to compliantly support the heart.
  • the prosthesis of this invention is lightweight and safe, and it can be adjusted after implantation without surgery as necessary to compensate for growth of the patient or other .factors that might alter the shape or volume of the patient's chest.
  • FIGURE 1 is a perspective view of a prosthesis manufactured in accordance with this invention.
  • FIGURE 2 illustrates the prosthesis of this invention in position in a person's chest, with the subcutaneous septal port located on the lower lateral portion of the patient's torso.
  • FIGURE 3 is a block diagram of a method of making a customized prosthesis in accordance with this invention.
  • a hollow balloon-like silicone prosthesis 10 is surgically inserted into the vacant chest cavity of a patient 11 who has undergone pneumonectomy.
  • Balloon 12 of the prosthesis 10 may be sized and shaped to occupy the vacant cavity so a.s to separate and support the walls of the chest cavity and the surrounding organs such as the heart and the remaining lung.
  • balloon 12 may be placed in the vacant chest cavity and filled to a volume necessary to assume the shape and size of the removed lung tissue. The thorax is then closed in layers. Any air surrounding the prosthesis 10 after closure will be resorbed by the patient's body.
  • the prosthesis 10 may be filled with any suitable fluid, either gaseous or liquid.
  • the prosthesis is gas filled, either with air or any other suitable gas or combination of gases. It . has been noted in experimental use of a balloon prosthesis in a dog that when a similar prosthesis is air filled it tends to lose volume due to transfer of oxygen molecules out of the balloon across the silicone membrane of the tested prosthesis.
  • the prosthesis is filled in part with sulfur hexafluoride (SF 6 ) , the large molecules of which are unable to permeate the silicone material of the prosthesis. Experiments have also revealed, however, that when the balloon is filled with SF 6 it tends to gain volume and pressure due to transfer of C0 2 across the silicone membrane into the balloon.
  • SF 6 sulfur hexafluoride
  • the prosthesis is filled with a mixture of air and SF 6 in a proportion that inhibits the prosthesis from either expanding or contracting due to transfer of gasses across the silicone membrane.
  • a preferred proportion of air to SF 6 is approximately 50% air to 50% SF 6 .
  • Light liquids such as silicone, as well as gaseous mixtures of air with other inert gases such as neon and krypton, may also be suitable for inflation of the prosthesis.
  • balloon 12 of the prosthesis is provided with a filling tube 14, the interior of which is in communication with the interior of balloon 12.
  • the tube 14 is placed in the patient's body such that its distal end 22 can be accessed by a physician without major surgery.
  • the distal end 22 may be, for example, extended exterior to the patient's body through an infection resistant cutaneous penetration, or it may be terminated subcutaneously.
  • distal end 22 of tube 14 is connected to a subcutaneous septal port 16.
  • the port is implanted under the patient's skin at an accessible location, and the physician can access the interior of the balloon/tube/port combination by sterilely inserting a hypodermic needle 20 through self-sealing septum 18 of port 16 for injecting and removing gases or other materials from the prosthesis.
  • the septum 18 will typically be self-sealing upon withdrawal of needle 20 therefrom.
  • prosthesis 10 is not under pressure, and the aforementioned access means is sufficient to prevent fluids from unintentionally entering or escaping the prosthesis 10 through septal port 16.
  • balloon 12 is constructed to be slightly larger than the chest cavity it is intended to occupy so that the balloon membrane is not under tension when filled to the selected volume.
  • balloon 12 is constructed approximately 10% larger than the chest cavity it is intended to occupy at the end of a normal exhalation.
  • balloon 12 of prosthesis 10 is designed to permit uniform, shape- retaining expansion.
  • This expandable embodiment is intended for implantation in children and youth, and it allows periodic non-surgical expansion of the prosthesis as the patient grows.
  • regions of the balloon that are under the most stress or strain during expansion may be made . thicker or reinforced with materials such as Dacron. Fluid may be added at a rate commensurate with the rate of growth of the patient's chest cavity.
  • the prosthesis is designed to expand in volume while retaining its overall shape and compliance, so its support function is maintained.
  • pressure relieving means may be provided for relieving excessively high pressure which may build up in the prosthesis 10 under certain unusual circumstances, causing undesirable pressure to be exerted by prosthesis 10 on the organs and structures surrounding the chest cavity. Pressure may be exerted by balloon 12 on the surrounding structures when the patient, for example, enters a region of lower ambient atmospheric pressure, for exampled, when the patient rides in an airplane or travels to high elevations.
  • the pressure relieving means may comprise, for example, a permeable panel in the subcutaneous infusion port which allows excess fluid to bleed into and be absorbed by the surrounding tissues, a pressure relief valve that vents excess fluid into a conduit which penetrates the patient's skin, or a normally empty reservoir bag 23 implanted subcutaneously and in communication with the balloon 12.
  • reservoir bag 23 is normally empty since the mean pressure in balloon prosthesis 12 is generally below ambient atmospheric pressure. However, should the fluid inside balloon 12 expand for any reason, the excess volume will be displaced into reservoir bag 23.
  • prosthesis 10 may be filled with a light liquid, such as liquid silicone, which would obviate the need for periodic volume adjustment and pressure relief means while maintaining the compliance of the prosthesis.
  • a light liquid such as liquid silicone
  • the balloon 12 and tube 14 of this prosthesis can be formed of any suitable bioco patible material, such as, for example, silicone materials, Mylar, and Dacron reinforced silicone material.
  • a material should be chosen which evokes minimal fibrotic tissue response and pleural inflammation, and which is adequately inert to be suitable for long-term implantation.
  • the rates at which the fluids interior and exterior to balloon 12 will pass through the chosen material, by osmosis or otherwise, should be taken into account when choosing the fluid or combination of fluids with which to fill balloon 12.
  • balloon 12 is constructed of silicone material, for example that used by CUI Corp. , Carpenteria, California, with a wall thickness of, for example, approximately 0.5 - 1.5 mm.
  • Filling tube 14 may be constructed of a like material with an interior diameter of 1.0 mm and a wall thickness of 0.5 mm.
  • a suitable subcutaneous septal port 16 is commercially available from CUI Corp.
  • balloon prostheses 10 of the present invention used experimentally in dogs have not experienced fluid influx and have remained gas-filled, although, as discussed above, gas transfer has been observed across the balloon membrane.
  • the balloon prosthesis 10 of this invention can be constructed to precisely fit into the chest cavity of a particular patient by a method for making balloon 12 comprising constructing a model of the patient's chest cavity using imaging means, building a mold for the balloon from the model, and manufacturing balloon 12 from the mold.
  • computerized imaging means 30 which may be, for example, magnetic resonance imaging or computerized tomographic imaging, is utilized to generate a three-dimensional computer model 32 of the patient's chest cavity or of the lung which is to be replaced by the prosthesis.
  • Computer model 32 may be obtained by the prosthesis fabricator from the hospital or clinic where the imaging is performed, or the •fabricator may obtain the imaging data and generate computer model 32 itself.
  • a physical model 34 of the chest cavity or lung may then be constructed from computer model 32 by conventional methods, for example using computerized machining equipment.
  • the computer model 32 may be used to make a plurality of physical "slices" of the computer modeled shape, which slices may be affixed together in proper alignment and orientation to produce a terraced physical model of the computer modeled shape.
  • the terraced surface of the model may then be smoothed by, for example, filling and cutting, to form physical model 34 of the patient's chest cavity.
  • Mold 36 may then be made from physical model 34 by conventional methods, and a custom fitted balloon 12 according to this invention may be constructed in mold 36 by molding methods well known in the art.
  • filling tube 14, septal port 16 and other selected devices, for example, pressure relieving means such as reservoir bag 23, may be attached to balloon 12 to form completed prosthesis 10.
  • a plurality of prostheses over a range of suitable sizes and shapes may be constructed and made available to the physician in a kit, who may then select the appropriate prosthesis 12 from the kit for each patient who requires such a device.
  • inventions disclosed herein are intended for human use as well as for veterinary use.

Abstract

A prosthesis (10) is provided to replace an excised lung, comprising a hollow balloon-like structure (12) formed generally in the shape of the lung, a filling tube, and a filling port. This prosthesis occupies the chest cavity left vacant after pneumonectomy to inhibit mediastinal shifting and overdistension and displacement of the remaining lung and other organs. This prosthesis also compliantly supports the heart and prevents the heart from contacting and adhering to other structures in the chest cavity. The volume of the prosthesis can be adjusted subsequent to implantation without subsequent surgery through a subcutaneous septal port (16). A combination of gases is selected to fill the prosthesis to minimize the volume change due to transfer of gas across the balloon membrane. Also provided are a method for preventing mediastinal shift and overdistension and displacement of organs following pneumonectomy using the prosthesis of this invention, and a method of making the prosthesis.

Description

DESCRIPTION
BALLOON PROSTHESIS FOR LUNG AND METHODS
BACKGROUND OF THE INVENTION
1. Field of the Invention This invention relates to prosthetic appliances for humans and other animals, and in particular it relates to a prosthetic device to occupy the chest cavity left vacant after excision of a lung. The prosthesis of this invention performs the separating and supporting functions performed by the lung, without interfering with the performance of the heart or any other organs and without impairing the breathing function of the remaining lung. This invention also relates to a method for making and using such a prosthesis.
Description of Related Art
The removal of one lung (i.e. pneumonectomy) is a surgical procedure not uncommonly performed for cancer, trauma, or infection of the lung. Prevention of overdistension of the remaining lung after pneumonectomy has been a concern to thoracis surgeons for many years. They anticipated that overdistension would cause distortions of remaining structures inside the thorax leading to abnormal heart and lung function. Many surgical procedures were designed to prevent overexpansion. In the 1940's investigators placed hollow lucite balls in the vacant chest cavities of dogs and humans to prevent overdistension of the remaining lung and to maintain the mediastinum in the midline following pneumonectomy. This work was described in Johnson et al . , Journal of Thoracic Surσery 18:164 (1949). Other substances and devices have been used to replace an excised lung and to correct the problems associated therewith, including gelatin foam, plastic sponge (Ivalon) and a polythene bag filled with fiberglass. Since the early 1960's these procedures have generally been abandoned as unnecessary.
More recently, it was noted that in several very young patients respiratory difficulties occurred after pneumonectomy due to tracheal kinking and deformity from marked mediastinal shift following pneumonectomy. A degree of success was reported by physicians who implanted silicone testicular and breast prostheses in the thoracic cavities of infants and young children to avoid and cure such difficulties, as was reported in Powell et al . , Journal of Pediatric Surgery 14:231 (1979) .
Success in correcting tracheal shift and overdistension of the remaining lung following pneumonectomy was also reported after implantation of silicone implants (similar to breast implants) in a 25 year old man in 1975, as was reported in Wasserman et al . , Chest 75:78 (1979).
Use of an expandable prosthesis to remedy problems associated with a removed lung was reported in Rasch et al , , Annals of Thoracic Surσerv 15:127 (1990). The reference indicated that an inflatable tissue expander with a subcutaneous injection port was implanted in a 5 month old infant. A 125-mL Surgitek inflatable tissue expander was inserted into the right pleural space and inflated with 60-mL of saline solution, which effectively returned the heart and mediastinal structures to near their natural positions. Five months after the operation the patient's respiratory difficulty returned and was relieved by injecting an additional 30-mL of saline solution into the prosthesis.
Numerous types of tissue expanders have been used by medical practitioners, such as those disclosed in, for example, U.S. Patent Nos. 4,095,295, 4,643,733, 4,800,901, 4,685,446, and 4,969,899. These are all designed for use in muscular and cutaneous tissue and are filled with a fluid or gelatinous material. Ordinary tissue expanders are not well suited for use as lung prostheses, however, because (a) they do not conform to the shape of the lung, so normal anatomy is not restored, (b) they generally contain saline, which is heavy and which does not restore normal compliance around the heart, and (c) they are not expandable to the extent required to permit implantation in a child and subsequent expansion to accommodate normal growth.
It has also been long known that the work tolerance of a human is significantly lowered following pneumonectomy, and it was assumed that the reduced tolerance was due to lowered respiratory capacity. The inventors and others have recently determined that the remaining lung is often adequate to supply the body's oxygen needs, and that the reduced ability to work is due to other physiological changes that occur after pneumonectomy. The heart is ordinarily held in place by the cardiac fossa, a compliant cavity formed largely by the shape of the lungs around the heart. When one lung is removed, it has been observed that the heart tends to be pushed against the rigid rib cage and to become attached thereto by fibrous tissue. These anatomical changes result in the heart muscle being surrounded by much less compliant structures than is normal, reducing the heart's ability to expand freely and thereby impairing cardiovascular performance. It is therefore desirable to provide a method of preventing mediastinal shift and overdistension and displacement of the visceral organs following pneumonectomy, and to provide a prosthesis to occupy the space in the chest cavity vacated after pneumonectomy to maintain a compliant cardiac fossa, to prevent the heart from being displaced from its normal position, to inhibit overdistension of the remaining lung, and to maintain the mediastinum near the midline. It is further desirable to provide as light a prosthesis as possible to reduce the work required to support it, while providing a safe and reliable device for long term implantation. Also, it is desirable that a lung prosthesis be adapted to permit adjustment to its volume by injection and withdrawal of fluid (liquid or gas) without additional surgery, and that the prosthesis be expandable to permit its use in a growing patient by periodically injecting additional fluid to increase the volume of the prosthesis. Finally, methods by which such a prosthetic device may be constructed and used are desired.
SUMMARY OF THE INVENTION
The goals outlined above are in large part achieved by the device and method of the present invention. A method of preventing mediastinal shift and overdistension and displacement of the remaining organs after pneumonectomy is provided. The lung prosthesis according to this invention is hollow and lightweight, yet it effectively and compliantly supports the heart and mediastinal structures and inhibits their movement from normal positions, preventing adhesion of the heart to other structures to avoid fibrous encasement of the heart. The prosthesis may be custom molded to fit the chest cavity into which it is intended to be placed and provided with a subcutaneous septal port which allows fluid to be injected into and withdrawn from the implanted prosthesis without additional surgery. An elastic material may be chosen to construct the prosthesis to permit volume changes as the patient grows.
A method is provided for custom molding a prosthesis according to this invention to match the size and shape of the chest cavity of each patient, although it may be feasible to provide a plurality of prostheses across a range of sizes, either individually or in a kit, from which a physician could select a suitable prosthesis. The prosthesis may be designed to allow for uniform expansion of the prosthesis to accommodate growth of a young patient while maintaining its anatomically correct shape over a range of volumes.
The custom molding method of making a balloon prosthesis comprises obtaining a computer model of the chest cavity the prosthesis is intended to occupy using non-invasive imaging techniques, for example, magnetic resonance imaging or computer to ographic (CT) scanning. A three dimensional physical model may be made based on the computer model, from which a mold may be constructed to form the balloon. The computer model may be generated at the hospital or clinic where the patient is examined and transferred to the balloon fabricator, or it may be generated by the fabricator.
The invention also includes a method for preventing mediastinal shift and overdistension and displacement of organs following pneumonectomy, comprising providing a prosthetic balloon as described herein, implanting it in a patient following pneumonectomy, filling the balloon with fluid, and adjusting the volume of the balloon as desired.- In a preferred embodiment, the balloon may be implanted at the time of surgery to remove the damaged lung, and the balloon may be filled to occupy the vacant chest cavity without being under tension and without applying pressure to the adjacent organs and structures. Subsequent to surgical implantation, the volume of the balloon may be adjusted without requiring surgery by accessing the subcutaneous septal port of the preferred embodiment with a hypodermic needle and selectively injecting or withdrawing fluid from the prosthesis.
In a preferred embodiment, the prosthesis may be filled with either gas or liquid. In a child where growth, is anticipated, a gaseous filler is desirable so the volume inside the prosthesis can be periodically adjusted, and the gas composition, may be selected to minimize volume change due to transfer of gas across the wall of the prosthesis. Once growth of the patient is complete and no further change in lung volume is anticipated, the gas may be withdrawn and replaced with a light liquid such as a silicone solution.
The present invention therefore provides an improved prosthesis for occupying the vacant chest cavity after a pneumonectomy. It also provides methods for making the prosthesis and for using the prosthesis to prevent or correct mediastinal shift and overdistension of the remaining lung, and to provide a substitute cardiac fossa to compliantly support the heart. The prosthesis of this invention is lightweight and safe, and it can be adjusted after implantation without surgery as necessary to compensate for growth of the patient or other .factors that might alter the shape or volume of the patient's chest. These and other advantages of the present invention will be further appreciated from the drawings and from the detailed description provided below. BRIEF DESCRIPTION OF THE DRAWINGS
So that the manner in which the herein described advantages and features of the present invention, as well as others which will become apparent, are attained and can be understood in detail, more particular description of the invention summarized above may be had by reference to the embodiment thereof which is illustrated in the appended drawings, which drawings form a part of this specification.
FIGURE 1 is a perspective view of a prosthesis manufactured in accordance with this invention.
FIGURE 2 illustrates the prosthesis of this invention in position in a person's chest, with the subcutaneous septal port located on the lower lateral portion of the patient's torso.
FIGURE 3 is a block diagram of a method of making a customized prosthesis in accordance with this invention.
It is to be noted, however, that the appended drawings illustrate only exemplary embodiments of the invention and are therefore not to be considered limiting of its scope, for the invention may admit to other equally effective embodiments.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
Referring to FIGURES 1 and 2, in a preferred embodiment a hollow balloon-like silicone prosthesis 10 is surgically inserted into the vacant chest cavity of a patient 11 who has undergone pneumonectomy. Balloon 12 of the prosthesis 10 may be sized and shaped to occupy the vacant cavity so a.s to separate and support the walls of the chest cavity and the surrounding organs such as the heart and the remaining lung. At surgery, after one lung or a portion thereof has been removed, balloon 12 may be placed in the vacant chest cavity and filled to a volume necessary to assume the shape and size of the removed lung tissue. The thorax is then closed in layers. Any air surrounding the prosthesis 10 after closure will be resorbed by the patient's body.
The prosthesis 10 may be filled with any suitable fluid, either gaseous or liquid. In a preferred embodiment, the prosthesis is gas filled, either with air or any other suitable gas or combination of gases. It . has been noted in experimental use of a balloon prosthesis in a dog that when a similar prosthesis is air filled it tends to lose volume due to transfer of oxygen molecules out of the balloon across the silicone membrane of the tested prosthesis. In a preferred embodiment, the prosthesis is filled in part with sulfur hexafluoride (SF6) , the large molecules of which are unable to permeate the silicone material of the prosthesis. Experiments have also revealed, however, that when the balloon is filled with SF6 it tends to gain volume and pressure due to transfer of C02 across the silicone membrane into the balloon. In a more preferred embodiment, the prosthesis is filled with a mixture of air and SF6 in a proportion that inhibits the prosthesis from either expanding or contracting due to transfer of gasses across the silicone membrane. Empirical observation indicates that a preferred proportion of air to SF6 is approximately 50% air to 50% SF6. Light liquids such as silicone, as well as gaseous mixtures of air with other inert gases such as neon and krypton, may also be suitable for inflation of the prosthesis.
To enable a physician to monitor and adjust the amount and composition of fluid in the prosthesis, means may be provided for non-surgical access to the interior of the prosthesis after implantation. Referring to FIGURE 1, in a preferred embodiment balloon 12 of the prosthesis is provided with a filling tube 14, the interior of which is in communication with the interior of balloon 12. The tube 14 is placed in the patient's body such that its distal end 22 can be accessed by a physician without major surgery. The distal end 22 may be, for example, extended exterior to the patient's body through an infection resistant cutaneous penetration, or it may be terminated subcutaneously. In a preferred embodiment, distal end 22 of tube 14 is connected to a subcutaneous septal port 16. The port is implanted under the patient's skin at an accessible location, and the physician can access the interior of the balloon/tube/port combination by sterilely inserting a hypodermic needle 20 through self-sealing septum 18 of port 16 for injecting and removing gases or other materials from the prosthesis. The septum 18 will typically be self-sealing upon withdrawal of needle 20 therefrom.
It is to be noted that, in a preferred embodiment, prosthesis 10 is not under pressure, and the aforementioned access means is sufficient to prevent fluids from unintentionally entering or escaping the prosthesis 10 through septal port 16. In a preferred embodiment balloon 12 is constructed to be slightly larger than the chest cavity it is intended to occupy so that the balloon membrane is not under tension when filled to the selected volume. For example and without limitation, in a preferred embodiment balloon 12 is constructed approximately 10% larger than the chest cavity it is intended to occupy at the end of a normal exhalation.
In an alternative embodiment, balloon 12 of prosthesis 10 is designed to permit uniform, shape- retaining expansion. This expandable embodiment is intended for implantation in children and youth, and it allows periodic non-surgical expansion of the prosthesis as the patient grows. In this embodiment and in other embodiments, regions of the balloon that are under the most stress or strain during expansion may be made . thicker or reinforced with materials such as Dacron. Fluid may be added at a rate commensurate with the rate of growth of the patient's chest cavity. The prosthesis is designed to expand in volume while retaining its overall shape and compliance, so its support function is maintained.
In a preferred embodiment, pressure relieving means may be provided for relieving excessively high pressure which may build up in the prosthesis 10 under certain unusual circumstances, causing undesirable pressure to be exerted by prosthesis 10 on the organs and structures surrounding the chest cavity. Pressure may be exerted by balloon 12 on the surrounding structures when the patient, for example, enters a region of lower ambient atmospheric pressure, for exampled, when the patient rides in an airplane or travels to high elevations.
The pressure relieving means may comprise, for example, a permeable panel in the subcutaneous infusion port which allows excess fluid to bleed into and be absorbed by the surrounding tissues, a pressure relief valve that vents excess fluid into a conduit which penetrates the patient's skin, or a normally empty reservoir bag 23 implanted subcutaneously and in communication with the balloon 12. In a preferred embodiment, referring to FIGURE 1, reservoir bag 23 is normally empty since the mean pressure in balloon prosthesis 12 is generally below ambient atmospheric pressure. However, should the fluid inside balloon 12 expand for any reason, the excess volume will be displaced into reservoir bag 23.
Alternatively, in a fully grown patient, prosthesis 10 may be filled with a light liquid, such as liquid silicone, which would obviate the need for periodic volume adjustment and pressure relief means while maintaining the compliance of the prosthesis.
The balloon 12 and tube 14 of this prosthesis can be formed of any suitable bioco patible material, such as, for example, silicone materials, Mylar, and Dacron reinforced silicone material. A material should be chosen which evokes minimal fibrotic tissue response and pleural inflammation, and which is adequately inert to be suitable for long-term implantation. The rates at which the fluids interior and exterior to balloon 12 will pass through the chosen material, by osmosis or otherwise, should be taken into account when choosing the fluid or combination of fluids with which to fill balloon 12. In a preferred embodiment balloon 12 is constructed of silicone material, for example that used by CUI Corp. , Carpenteria, California, with a wall thickness of, for example, approximately 0.5 - 1.5 mm. Filling tube 14 may be constructed of a like material with an interior diameter of 1.0 mm and a wall thickness of 0.5 mm. A suitable subcutaneous septal port 16 is commercially available from CUI Corp.
Contrary to the expectations of some practitioners, balloon prostheses 10 of the present invention used experimentally in dogs have not experienced fluid influx and have remained gas-filled, although, as discussed above, gas transfer has been observed across the balloon membrane. The balloon prosthesis 10 of this invention can be constructed to precisely fit into the chest cavity of a particular patient by a method for making balloon 12 comprising constructing a model of the patient's chest cavity using imaging means, building a mold for the balloon from the model, and manufacturing balloon 12 from the mold.
Referring to FIGURE 3, in a preferred method of creating a customized prosthesis, computerized imaging means 30, which may be, for example, magnetic resonance imaging or computerized tomographic imaging, is utilized to generate a three-dimensional computer model 32 of the patient's chest cavity or of the lung which is to be replaced by the prosthesis. Computer model 32 may be obtained by the prosthesis fabricator from the hospital or clinic where the imaging is performed, or the •fabricator may obtain the imaging data and generate computer model 32 itself. A physical model 34 of the chest cavity or lung may then be constructed from computer model 32 by conventional methods, for example using computerized machining equipment. Alternatively, the computer model 32 may be used to make a plurality of physical "slices" of the computer modeled shape, which slices may be affixed together in proper alignment and orientation to produce a terraced physical model of the computer modeled shape. (The terraced surface of the model may then be smoothed by, for example, filling and cutting, to form physical model 34 of the patient's chest cavity.) Mold 36 may then be made from physical model 34 by conventional methods, and a custom fitted balloon 12 according to this invention may be constructed in mold 36 by molding methods well known in the art. Finally, filling tube 14, septal port 16 and other selected devices, for example, pressure relieving means such as reservoir bag 23, may be attached to balloon 12 to form completed prosthesis 10. In an alternative method, rather than customizing each prosthesis 12 to fit a particular patient, a plurality of prostheses over a range of suitable sizes and shapes may be constructed and made available to the physician in a kit, who may then select the appropriate prosthesis 12 from the kit for each patient who requires such a device.
The inventions disclosed herein are intended for human use as well as for veterinary use.
Further modifications and alternative embodiments of this invention will be apparent to those skilled in the art in view of this description. Accordingly, this description is to be construed as illustrative only and is for the purpose of teaching those skilled in the art the manner of carrying out the invention. It is to be understood that the forms of the invention herein shown and described are to be taken as the presently preferred embodiments. Various changes may be made in the shape, size, and arrangement of parts. For example, equivalent elements or materials may be substituted for those illustrated and described herein, and certain features of the invention may be utilized independently of the use or other features, all as would be apparent to one skilled in the art after having the benefit of this description of the invention.

Claims

1. A prosthesis to occupy a chest cavity having a predetermined shape and size left vacant after excision - of a lung or a portion of a lung, comprising:
a hollow balloon forming an enclosed volume adapted to occupy the chest cavity and formed in substantially the shape and size of the chest cavity, the balloon being made of a bioco patible material;
a filling tube made of a biocompatible material having a first end and a second end, the first end being connected to the balloon; and
a subcutaneous septal port connected to the second end of the filling tube, the port having a self-sealing surface adapted to be penetrated by a hypodermic needle.
2. The prosthesis of claim 1, further comprising:
a gaseous mixture comprising an inert gas occupying the enclosed volume formed by the balloon.
3. The prosthesis of claim 2 , wherein the inert gas comprises sulfur hexafluoride.
4. The prosthesis of claim 1, further comprising:
a liquid solution comprising silicone occupying the enclosed volume formed by the balloon.
5. The prosthesis of claim l, wherein the balloon is constructed from silicone material.
6. The prosthesis of claim 1, wherein the balloon is a selected amount larger in size than the chest cavity it is intended to occupy.
7. A prosthesis to occupy a chest cavity having a predetermined shape and size left vacant after excision of a lung or a portion thereof, comprising:
a hollow balloon forming an enclosed volume adapted to occupy the chest cavity and formed in substantially the shape and size of the chest cavity, the balloon being made of a biocompatible material;
a filling tube made of a biocompatible material having a first end and a second end, the first end being connected to the balloon;
a subcutaneous septal port connected to the second end of the filling tube, the port having a self-sealing surface adapted to be penetrated by a hypodermic needle; and
pressure relieving means adapted to permit fluid to exit the balloon to prevent the balloon from exerting excessive pressure upon surrounding organs when the fluid in the balloon expands.
8. The prosthesis of claim 7, wherein the pressure relieving means comprises a subcutaneous reservoir bag adapted to accept fluid from the balloon.
9. The prosthesis of claim 7, wherein the pressure relieving means comprises a permeable panel located on the subcutaneous septal port adapted to permit fluid to exit the prosthesis and be absorbed into surrounding tissue.
10. The prosthesis of claim 7, further comprising:
a gaseous mixture comprising an inert gas occupying the enclosed volume formed by the balloon.
11. The prosthesis of claim 10, wherein the inert gas comprises sulfur hexafluoride.
12. The prosthesis of claim 7, further comprising:
a liquid solution comprising silicone occupying the enclosed volume formed by the balloon.
13. The prosthesis of claim 7, wherein the balloon is constructed from silicone material.
14. The prosthesis of claim 7, wherein the balloon is a selected amount larger than the chest cavity it is intended to occupy.
15. A method for preventing mediastinal shift and overdistension and displacement of organs following pneumonectomy , comprising: providing a prosthesis comprising a hollow balloon formed in substantially the shape and size of the lung it is intended to replace, the balloon being manufactured from a biocompatible material and filled with fluid; a filling tube manufactured from a biocompatible material having a first end and a second end, the first end being connected to the balloon; and a subcutaneous septal port connected to the second end of the filling tube, the port having a self-sealing surface adapted to be penetrated by a hypodermic needle;
surgically implanting the balloon of the prosthesis in a vacant chest cavity;
positioning the filling tube leading from the balloon to a site selected from implanting the subcutaneous septal port;
implanting the subcutaneous septal port at the selected site; and
filling the balloon to a selected volume with fluid.
16. The method of claim 15, further comprising adjusting the volume of the balloon by penetrating the self-sealing surface of the subcutaneous septal port with a hypodermic needle and adding fluid to or removing fluid from the prosthesis.
17. A method of making a balloon prosthesis for a lung, comprising:
obtaining a computer model of the chest cavity; forming a physical model of the chest cavity from the computer model;
constructing a mold from the physical model; and
molding a hollow balloon in the mold using a biocompatible material, such that the balloon is substantially the size and shape of the chest cavity.
18. The method of claim 17, wherein the obtained computer model is based on data obtained from magnetic resonance imaging techniques.
19. The method of claim 17, wherein the obtained computer model is based on data obtained from the computerized tomographic imaging techniques.
20. A kit for use by physicians, said kit comprising a plurality of balloon prostheses from which a physician can select a balloon prosthesis of a size and shape suitable to occupy a chest cavity having a determinable size and shape vacated after a lung is excised from a patient, said prostheses being made of biocompatible materials and formed in substantially the sizes and shapes of the chest cavities they are intended to occupy.
PCT/US1992/010252 1991-11-27 1992-11-27 Balloon prosthesis for lung and methods WO1993010723A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US800,509 1977-05-25
US80050991A 1991-11-27 1991-11-27

Publications (1)

Publication Number Publication Date
WO1993010723A1 true WO1993010723A1 (en) 1993-06-10

Family

ID=25178581

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1992/010252 WO1993010723A1 (en) 1991-11-27 1992-11-27 Balloon prosthesis for lung and methods

Country Status (2)

Country Link
AU (1) AU3149593A (en)
WO (1) WO1993010723A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994016630A1 (en) * 1993-01-19 1994-08-04 Loma Linda University Medical Center Inflatable endoscopic retractor
WO1996012518A1 (en) * 1994-10-20 1996-05-02 Children's Medical Center Corporation Systems and methods for promoting tissue growth
US6048330A (en) * 1994-10-20 2000-04-11 Children's Medical Center Corporation Systems and methods for promoting tissue growth
US6653525B2 (en) * 2001-01-18 2003-11-25 The Brigham And Women's Hospital, Inc. Prosthetic device for respiratory patients
US10258457B1 (en) * 2018-07-04 2019-04-16 Ghassan E. Jweied Dynamic dual chamber breathing prosthesis and methods

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4044401A (en) * 1975-08-04 1977-08-30 Jacques Guiset Artificial bladder
US4651717A (en) * 1985-04-04 1987-03-24 Dow Corning Corporation Multiple envelope tissue expander device
US4828560A (en) * 1988-02-17 1989-05-09 Mcgman Medical Corporation Spring ring tissue expander
US4969899A (en) * 1989-03-08 1990-11-13 Cox-Uphoff International Inflatable implant

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4044401A (en) * 1975-08-04 1977-08-30 Jacques Guiset Artificial bladder
US4651717A (en) * 1985-04-04 1987-03-24 Dow Corning Corporation Multiple envelope tissue expander device
US4828560A (en) * 1988-02-17 1989-05-09 Mcgman Medical Corporation Spring ring tissue expander
US4969899A (en) * 1989-03-08 1990-11-13 Cox-Uphoff International Inflatable implant

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994016630A1 (en) * 1993-01-19 1994-08-04 Loma Linda University Medical Center Inflatable endoscopic retractor
US5588951A (en) * 1993-01-19 1996-12-31 Loma Linda University Medical Center Inflatable endoscopic retractor with multiple rib-reinforced projections
WO1996012518A1 (en) * 1994-10-20 1996-05-02 Children's Medical Center Corporation Systems and methods for promoting tissue growth
US5858003A (en) * 1994-10-20 1999-01-12 Children's Medical Center Corporation Systems and methods for promoting tissue growth
US6048330A (en) * 1994-10-20 2000-04-11 Children's Medical Center Corporation Systems and methods for promoting tissue growth
US6287275B1 (en) 1994-10-20 2001-09-11 Children's Medical Center Corporation Systems and methods for promoting tissue growth
US6432081B1 (en) 1994-10-20 2002-08-13 Children's Medical Center Corporation Systems and methods for promoting tissue growth
US6653525B2 (en) * 2001-01-18 2003-11-25 The Brigham And Women's Hospital, Inc. Prosthetic device for respiratory patients
US10258457B1 (en) * 2018-07-04 2019-04-16 Ghassan E. Jweied Dynamic dual chamber breathing prosthesis and methods
WO2020010266A1 (en) * 2018-07-04 2020-01-09 Jweied Ghassan E Dynamic dual chamber breathing prosthesis and methods

Also Published As

Publication number Publication date
AU3149593A (en) 1993-06-28

Similar Documents

Publication Publication Date Title
US5578085A (en) Balloon prosthesis for the lung and methods of making and using same
US3900033A (en) Dilator for cervical canal
KR101301458B1 (en) Adjustable vaginal splint for pelvic floor support
CN101909534B (en) Porous containment device for stabilization of vertebral compression fractures
US4969888A (en) Surgical protocol for fixation of osteoporotic bone using inflatable device
AU596094B2 (en) Multiple envelope tissue expander device
BR112019006991B1 (en) NEOPHALUS IMPLANT
CN109316279A (en) Negative pressure wound closure device
US7615074B2 (en) Method and apparatus for reconstructive surgery
US11944533B2 (en) Implantable prostheses for tissue expansion
CN106413601A (en) Methods and devices for treating a hyper-inflated lung
JPH10506556A (en) Method and apparatus for establishing a stable living body pocket
US4586505A (en) Laryngeal and tracheal stent
BR112021001249B1 (en) PENILE IMPLANT
BRPI0408904B1 (en) Cystocele treatment implant and device for implant insertion
WO1993010723A1 (en) Balloon prosthesis for lung and methods
JP7379392B2 (en) Inflatable ports, catheter assemblies including inflatable ports, and methods thereof
Robin et al. Experimental scoliosis in primates: Failure of a technique
US20060173484A1 (en) Percutaneous breast and buttock modification
Fisher et al. Experimental tissue molding for soft-tissue reconstruction: a preliminary report
CN212186772U (en) Movable space occupying device
RU2435525C1 (en) Method of covering defect of larynx and/or trachea
EP2566396A1 (en) Device for sealing perforations and sustaining flow
ES2792984T3 (en) Ribbed dilator for the implantation of a penile prosthesis
AU2022234745A1 (en) Sinus implant

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AT AU BB BG BR CA CH CS DE DK ES FI GB HU JP KP KR LK LU MG MN MW NL NO PL PT RO RU SD SE UA

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase